1. Huvis Q2 2025 Earnings: What Happened?
Huvis recorded sales of KRW 29.1 billion, operating profit of KRW 1.8 billion, and a net loss of KRW 1.4 billion in Q2 2025. While sales slightly decreased compared to the previous quarter, both operating profit and net income fell sharply, resulting in a net loss.
2. Reasons for the Decline
The main factors contributing to this underperformance are:
- • Global economic slowdown and sluggish Chinese market
- • Impact of foreign exchange fluctuations
- • Increase in R&D expenses
- • Investment costs for new businesses, such as the dental business
3. Future Outlook
Huvis has growth potential, driven by the expanding ophthalmic market, dental business expansion, and the acquisition of Osvis. However, the Q2 earnings decline, foreign exchange volatility, and the sluggish Chinese market pose short-term risks.
4. Investment Strategies
Investors should approach with caution in the short term, considering potential stock price volatility. In the medium to long term, close monitoring of profitability improvement is crucial. Key factors to watch include managing foreign exchange volatility, improving R&D investment efficiency, and reviewing the China market strategy. The performance of the dental business should also be carefully observed.